Department of Oncological Urology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
Urology, Western Hospital Unit "San Pio", Castellaneta, Italy.
Int Urol Nephrol. 2024 Jan;56(1):121-127. doi: 10.1007/s11255-023-03766-z. Epub 2023 Aug 30.
We report a comparative monocentric study with a short and long-term follow-up with the aim to assess differences about urinary continence outcomes in patients treated with Robot-Assisted Radical Prostatectomy (RARP) with two different techniques: with anterior and posterior reconstruction and without any kind of reconstruction.
From January 2016 to September 2021, at the Department of Urology of the "F. Miulli" Hospital of Acquaviva delle Fonti, in Italy, 850 eligible patients underwent extraperitoneal RARP with anterior and posterior reconstruction and 508 without reconstructions.
In patients undergoing RARP with reconstructions 1 month after surgery the urinary continence was preserved in 287/850 patients (33.8%), 3 months after surgery in 688/850 (81%), 6 months in 721/850 (84.8%), 12 months in 734/850 (86.3%), 18 months in 671/754 (89%), 24 months in 696/754 (92.3%), 36 months in 596/662 (90%), 48 months in 394/421 (93.6%), 60 months in 207/212 (97.6%). In patients undergoing RARP without reconstruction 1 month after surgery urinary continence was preserved in 99/508 (19.4%), after 3 months in 276/508 (54.3%), 6 months in 305/508 (60%), 12 months in 329/508 (64.7%), 18 months in 300/456 (65.7%), 24 months in 295/456 (64.7%), 36 months in 268/371 (72.3%), 48 months in 181/224 (81%), 60 months in 93/103 (90.3%).
In our case study, the RARP with anterior and posterior reconstruction technique is associated with a statistically significant higher rate (up to 48 months of follow-up) and a faster recovery of urinary continence compared to the technique without reconstructions.
我们报告了一项具有短期和长期随访的中心对比研究，旨在评估机器人辅助前列腺根治性切除术（RARP）中两种不同技术（有前后重建和无任何重建）的尿控结果差异。
2016 年 1 月至 2021 年 9 月，在意大利 Acquaviva delle Fonti 的“F. Miulli”医院泌尿科，850 名符合条件的患者接受了腹膜外 RARP 联合前后重建，508 名患者未进行重建。
在接受 RARP 联合重建的患者中，术后 1 个月时，850 例患者中有 287 例（33.8%）保留了尿控，术后 3 个月时，850 例患者中有 688 例（81%）保留了尿控，术后 6 个月时，850 例患者中有 721 例（84.8%）保留了尿控，术后 12 个月时，850 例患者中有 734 例（86.3%）保留了尿控，术后 18 个月时，754 例患者中有 671 例（89%）保留了尿控，术后 24 个月时，754 例患者中有 696 例（92.3%）保留了尿控，术后 36 个月时，662 例患者中有 596 例（90%）保留了尿控，术后 48 个月时，421 例患者中有 394 例（93.6%）保留了尿控，术后 60 个月时，212 例患者中有 207 例（97.6%）保留了尿控。在接受 RARP 无重建的患者中，术后 1 个月时，508 例患者中有 99 例（19.4%）保留了尿控，术后 3 个月时，508 例患者中有 276 例（54.3%）保留了尿控，术后 6 个月时，508 例患者中有 305 例（60%）保留了尿控，术后 12 个月时，508 例患者中有 329 例（64.7%）保留了尿控，术后 18 个月时，456 例患者中有 300 例（65.7%）保留了尿控，术后 24 个月时，456 例患者中有 295 例（64.7%）保留了尿控，术后 36 个月时，371 例患者中有 268 例（72.3%）保留了尿控，术后 48 个月时，324 例患者中有 181 例（81%）保留了尿控，术后 60 个月时，303 例患者中有 93 例（90.3%）保留了尿控。
在我们的病例研究中，与无重建技术相比，RARP 联合前后重建技术具有更高的尿控率（随访至 48 个月）和更快的尿控恢复速度。
Zotero 插件